Sochinaz has gained extensive experience in the process-development and manufacturing of HPAIs (high-potency active ingredients) such as:

the synthesis of cytotoxic / cytostatic small organic APIs

the coupling of cytotoxic / cytostatic moieties to peptides in collaboration with the   Bachem Group of Companies.